BioSpectrum Asia - April 2017Add to Favorites

Get BioSpectrum Asia along with 7,500+ other magazines & newspapers

Try FREE for 7 days

bookLatest and past issues of 7,500+ magazines & newspapersphoneDigital Access. Cancel Anytime.familyShare with 4 family members.

1 Year$99.99

bookLatest and past issues of 7,500+ magazines & newspapersphoneDigital Access. Cancel Anytime.familyShare with 4 family members.
(Or)

Get BioSpectrum Asia

1 Year $10.99

Save 7%
book12 issues starting from BioSpectrum Asia October 2022 phoneDigital Access. Cancel Anytime.

Buy this issue $0.99

bookApril 2017 issue phoneDigital Access.

Gift BioSpectrum Asia

  • Magazine Details
  • In this issue

Magazine Description

In this issue

In 2016, the US Food and Drug Administration (FDA) approved 22 new drugs which was way lower than 2015 when 45 new drugs were launched. It was a year of disappointment for pharmaceutical companies and drug developers. However, the industry is optimistic that research on novel drugs has not slowed down and wheels of innovation is spinning ahead. BioSpectrum Asia takes a look at the drugs that are in phase III of clinical trial or have been recently approved. These drugs are indicated for life threatening diseases and once available in the market, they would be effective in battling the disease burden.

  • cancel anytimeCancel Anytime [ No Commitments ]
  • digital onlyDigital Only
RECENT STORIES FROM BIOSPECTRUM ASIAView All